---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-050683"
form_type: "8-K"
ticker: "FHTX"
cik: "0001822462"
company_name: "Foghorn Therapeutics Inc."
filed_at: "2025-11-07T23:59:59+00:00"
generated_at: "2026-05-16T23:07:04.610860+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Foghorn Therapeutics releases November 2025 investor presentation highlighting precision therapeutics

## Summary
- Presentation dated November 2025 focuses on the company's unique biology and precision therapeutics platform.
- No specific financial results or operational updates disclosed in the filing.
- The presentation is intended for use in meetings with investors.

## SEC filing metadata
- accession: 0001628280-25-050683
- form_type: 8-K
- ticker: FHTX
- cik: 0001822462
- company_name: Foghorn Therapeutics Inc.
- filed_at: 2025-11-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822462/000162828025050683/0001628280-25-050683-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822462/000162828025050683/fhtx-20251107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-050683
- JSON: https://secwatch.observer/filing/0001628280-25-050683.json
- Plain text: https://secwatch.observer/filing/0001628280-25-050683.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.